Brief: Sun Pharma signs 410 mln rupees deal with RPG Life Sciences
July 27 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS : * Signed an agreement with RPG Life Sciences Ltd to divest seven prescription brands in India * Deal for a consideration of 410 million rupees * 7 divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment * Source text: (http://bit.ly/2a4dtjD) * Further company coverage SUN.NS ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on RPG Life Sciences
See all newsBrief: RPG Life Sciences June-Quarter Consol Profit 307.6 Million Rupees
Brief: RPG Life Sciences Partners With Archerchem Healthcare For Naprosyn ES Launch
Brief: RPG Life Sciences March-Quarter Consol Profit 299 Million Rupees
India's RPG Life Sciences hits 9-month low on quarterly profit fall
Brief: RPG Life Sciences Dec-Quarter Consol Profit 221.3 Million Rupees